Literature DB >> 28889282

Enzymatic Production of c-di-GMP Using a Thermophilic Diguanylate Cyclase.

Prabhadevi Venkataramani1, Zhao-Xun Liang2.   

Abstract

C-di-GMP has emerged as a prevalent bacterial messenger that controls a multitude of bacterial behaviors. Having access to milligram or gram quantities of c-di-GMP is essential for the biochemical and structural characterization of enzymes and effectors involved in c-di-GMP signaling. Although c-di-GMP can be synthesized using chemical methods, diguanylate cyclases (DGC)-based enzymatic synthesis is the most efficient method of preparing c-di-GMP today. Many DGCs are not suitable for c-di-GMP production because of poor protein stability and the presence of a c-di-GMP-binding inhibitory site (I-site) in most DGCs. We have identified and engineered a thermophilic DGC for efficient production of c-di-GMP for characterizing c-di-GMP signaling proteins and riboswitches. Importantly, residue replacement in the inhibitory I-site of the thermophilic DGC drastically relieved product inhibition to enable the production of hundreds of milligrams of c-di-GMP using 5-10 mg of this robust biocatalyst.

Keywords:  Diguanylate cyclase; Thermophilic enzyme; Thermotoga maritima; c-di-GMP

Mesh:

Substances:

Year:  2017        PMID: 28889282     DOI: 10.1007/978-1-4939-7240-1_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Structural analyses unravel the molecular mechanism of cyclic di-GMP regulation of bacterial chemotaxis via a PilZ adaptor protein.

Authors:  Xin-Fu Yan; Lingyi Xin; Jackie Tan Yen; Yukai Zeng; Shengyang Jin; Qing Wei Cheang; Rachel Andrea Chea Yuen Fong; Keng-Hwee Chiam; Zhao-Xun Liang; Yong-Gui Gao
Journal:  J Biol Chem       Date:  2017-11-16       Impact factor: 5.157

2.  Highly Efficient Preparation of Cyclic Dinucleotides via Engineering of Dinucleotide Cyclases in Escherichia coli.

Authors:  Yun Lv; Qichao Sun; Xiaodan Wang; Yi Lu; Yaoyao Li; Huiqing Yuan; Jing Zhu; Deyu Zhu
Journal:  Front Microbiol       Date:  2019-09-13       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.